Cyclosporine-induced syngeneic graft-versus-host disease: recognition of self MHC class II antigens in vivo.
Hess
A D
AD
Johns Hopkins Bone Marrow Transplant Unit, Baltimore, Maryland.
Horwitz
L R
LR
Laulis
M K
MK
D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D016026:Bone Marrow Transplantation / Q000276:immunology*; D016572:Cyclosporine / Q000633:toxicity*; D005260:Female; D006086:Graft vs Host Disease / Q000276:immunology*; D015395:Histocompatibility Antigens Class I / Q000276:immunology; D000949:Histocompatibility Antigens Class II / Q000276:immunology*; D016219:Immunotherapy, Adoptive; D051381:Rats; D011917:Rats, Inbred Lew; D014185:Transplantation, Isogeneic / Q000276:immunology; D014916:Whole-Body Irradiation
D000911:Antibodies, Monoclonal; D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II; D016572:Cyclosporine